Reaction

Genital Infection Fungal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 816 reports · 4 co-occurring drugs

As of the last recalculation, Genital Infection Fungal appears in 816 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is CANAGLIFLOZIN (PRR 364.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Canagliflozin281364.8368.3
Empagliflozin10344.544.6
Dapagliflozin1915.815.8
Bimekizumab56.06.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.